Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() 250 Million EUR Research Programme on Neurodegeneration Featured at Alzheimer Europe ConferenceNeuronet Public Event Features Major European Research Projects on Alzheimer's Disease and Beyond During the Alzheimer Europe Conference 2019 in The Hague, Taking Place on 24–25 October.
By: Alzheimer Europe The Neuronet sessions will introduce the IMI and its neurodegeneration portfolio. The programme is listed below: Thursday, 24 October, 10.30-12.00 Parallel session P5. European research collaboration in Alzheimer's disease and beyond The Innovative Medicines Initiative and its neurodegeneration portfolio Neuronet – Efficiently Networking European Neurodegeneration Research Patient and Public Involvement in the IMI research portfolio Thursday, 24 October, 14.00-15.30 Parallel session P13. From risk to dementia – Understanding disease progression and its causes ADAPTED – Alzheimer's disease apolipoprotein pathology for treatment elucidation and development PHAGO – Targeting TREM2 and CD33 of phagocytes for treatment of Alzheimer's disease AETIONOMY – Disease Mechanisms for Patient Subgroup Identification and Disease Progression Modeling Friday, 25 October, 10.30-12.00 Parallel session P21. Improving data access and the development of predictive models EQIPD – Data quality in preclinical research EMIF – European Medical Information Framework ROADMAP – Real world outcomes across the AD spectrum IM2PACT – Discovery of blood-brain barrier targets and transport pathways to treat neuro/metabolic diseases – A public-private partnership Friday, 25 October, 14.00-15.30 Parallel session P29. Diagnosis, patient engagement and trials AMYPAD – Amyloid imaging to prevent Alzheimer's disease EPAD – European prevention of Alzheimer's dementia consortium MOPEAD – Models of Patient Engagement in Alzheimer's Disease: a European project to develop and test innovative patient engagement strategies RADAR-AD – Remote Assessment of functional decline in Alzheimer's Disease For more information visit: https://www.imi- End
|
|